Taking Pharma and Biotech R&D Mobile

Formed out of a Shire and Genzyme leadership experience, iTakeControl is bringing mobile to biopharmaceutical research and development across the spectrum of both clinical and other R&D programs.

From a partnership with Drexel University on the development of a real world research application for binge eating to a phase 3 pivotal trial with caregiver video assessments, iTakeControl is looking to lead the industry in mobile solutions for R&D.

Get to know us better…

2015

Year of foundation

16

Passionate team members

3

Locations

pic

Validating Quality at Every Step

Our rigorous process ensures your project is managed strategically and efficiently on our industry standard platform from initial conception through final delivery.

Dalia El-Sherif, Ph.D.
Co-Founder and CEO

With over twenty plus years of experience, Dalia’s unique background blends entrepreneurship and management consulting in the pharmaceutical, medical device and healthcare industries, delivering innovative solutions in research, operations, strategy, and technology.

Dalia was a top strategy/change consultant at PA Consulting and IBM, as well as a top performer at Shire. At PA and IBM, Dalia successfully led over twenty strategic projects in over fourteen accounts. At Shire, Dalia led the Strategic Planning and Portfolio Management function for Shire’s Specialty Pharma division, where she delivered a Presidents Club award winning strategic 2020 roadmap. In her role as head of Strategic Planning and Portfolio Management Dalia drove the establishment of Shire’s Big Data and Advanced Analytics capability as well as established a roadmap for strategic and innovative development of mobile and gaming solutions. ​Dalia is also a Partner at Pyxa Solutions, LLC, which focuses on services that drive Cross-Functional R&D Excellence.

Christopher Jones, Ph.D.
Co-Founder and Executive Vice President

Chris has over twenty years of experience growing businesses and advising organizations through innovation and the adoption of digital technology in the biotech industry. In addition to his role in iTakeControl, he also leads CJ Jones Strategy & Communications, a consulting company in real-world evidence and registry studies. Prior to that, he led the strategy and development of a real world data analytics platform in the disease registry space. He spent ten years with Genzyme Corporation, heading the digital marketing programs in the Rare Genetic Disease group and in senior positions in Medical Affairs.

Oleksandr Topachevskyi, MSc.
CTO

Alex has over 10 years of experience in health economics evaluations and modeling. He has designed and implemented digital innovations in global pharmaceutical HQ GlaxoSmithKline Vaccines and has over 20 scientific publications in peer review journals. MSc. in Health Economics & Modeling, University of York, United Kingdom. He is the founder of a digital health consulting agency, Digital Health Outcomes.

Andrew Volovyk, M.A.
Engineering & UX Lead

Andrew has over 10 years of experience in software & web development and UI / UX. He has completed over 70 projects and led product design for a 2016 Y-combinatory backed startup. He is also the cofounder of the best Ukrainian startup of 2013 Hashtago. Andrew has a MA in Computer Science and Applied Math from Taras Shevchenko national university of Kyiv.

pic

Trying to understand mobile in your R&D plans?

WE CAN HELP